Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Journal of Managed Care & Specialty Pharmacy|September 26, 2025
Trends in opioid prescribing by oncologists for Medicare beneficiaries from 2014 to 2022Shaimaa Elshafie, Lorenzo Villa ZapataAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 2, 2026
Adherence to antituberculous medication regimens in the United States: Insights from MarketScan databases, 2016-2022Pooja Gokhale, Lorenzo Villa ZapataJournal of Cancer Survivorship : Research and Practice|December 19, 2025
Association of telehealth use with endocrine therapy adherence, metastasis incidence and healthcare costs in breast cancer: A claims-based cohort studyShaimaa Elshafie, Lorenzo Villa ZapataThe American Journal of Managed Care|November 25, 2025
Cost-effectiveness analysis of ubrogepant, rimegepant, and zavegepant for acute migraine treatment vs usual carePooja Gokhale, Lorenzo Villa ZapataCancer Medicine|April 2, 2026
Immune-Related Adverse Events in Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors: Insights From a FAERS Disproportionality AnalysisPooja Gokhale, Lorenzo Villa ZapataAmerican Journal of Infection Control|June 28, 2025
Opioid use and risk of Clostridioides difficile infection in hospitalized patients: A systematic review and meta-analysisPooja Gokhale, Lorenzo Villa ZapataJournal of Huntington'S Disease|February 20, 2025
Economic burden of Huntington's disease: A systematic reviewPooja Gokhale, Lorenzo Villa ZapataPharmacy World & Science : PWS|August 21, 2008
Analysis and quantification of self-medication patterns of customers in community pharmacies in southern ChileKatherine Fuentes Albarrán, Lorenzo Villa ZapataJournal of Clinical Pharmacy and Therapeutics|June 5, 2020
Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving StudyDaniel Muñoz-Pichuante, Lorenzo Villa-ZapataThe Annals of Pharmacotherapy|February 13, 2024
Exploring Safety in Gender-Affirming Hormonal Treatments: An Observational Study on Adverse Drug Events Using the Food and Drug Administration Adverse Event Reporting System DatabaseAinhoa Gomez-Lumbreras, Lorenzo Villa-ZapataPageof 6